SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sanofi's quarterly cash and cash equivalents increased from Sep. 2013 ($0 Mil) to Dec. 2013 ($11,249 Mil) but then declined from Dec. 2013 ($11,249 Mil) to Mar. 2014 ($0 Mil).
Sanofi's annual cash and cash equivalents increased from Dec. 2011 ($5,321 Mil) to Dec. 2012 ($8,485 Mil) and increased from Dec. 2012 ($8,485 Mil) to Dec. 2013 ($11,249 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Sanofi Annual Data
Sanofi Quarterly Data